![](/img/cover-not-exists.png)
Re: Cost-effectiveness of combination daclatasvir-sofosbuvir for the treatment of genotype 3 chronic hepatitis C infection in the United States
Patel, Jayeshkumar, Zhao, Xiaohui, Shah, Drishti, Alhussain, Khalid, Kamal, KhalidLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2017.1360310
Date:
July, 2017
File:
PDF, 583 KB
english, 2017